-+ 0.00%
-+ 0.00%
-+ 0.00%

Clear Street Maintains Buy on WAVE Life Sciences, Raises Price Target to $47

Benzinga·12/09/2025 12:20:15
语音播报
Clear Street analyst Bill Maughan maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $22 to $47.